Nimixa®

Nimixa®

Therapeutic Segment: Antibiotic

Generic Name: Rifaximin

Indication:
  • 200mg dose is indicated for the treatment of patients (> 12 years of age) with traveler’s diarrhea caused by noninvasive strains of Escherichia coli.
  • 550mg dose is indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients 18 years of age.

Available as:

Tablets
  • 500MG
  • 200MG